Montelukast Teva (Montelukast Sodium)

Montelukast Sodium, the active ingredient in Montelukast Teva, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma and allergic rhinitis in adults and children. GNH USA supplies Montelukast Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast Teva is a leukotriene‑receptor antagonist used in the management of chronic airway and nasal allergic conditions.

- Asthma: reduces the frequency of bronchospasm and improves overall disease control. - Allergic rhinitis: relieves nasal congestion, sneezing, itching and rhinorrhea. - Exercise‑induced bronchoconstriction: prevents symptoms triggered by physical activity.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported. - Abdominal pain: discomfort or cramping in the stomach region. - Cough: occasional dry or productive cough. - Nausea: feeling of queasiness without vomiting. - Sore throat: irritation or pain in the throat. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips or tongue. - Mood changes: depression, anxiety, or suicidal thoughts. - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Hepatic injury: elevated liver enzymes or hepatitis. - Anaphylaxis: life‑threatening allergic reaction. - Eosinophilic pneumonia: rare lung inflammation with eosinophil accumulation.

Use Montelukast with awareness of specific safety considerations.

- Pregnancy: consult a healthcare provider; safety data are limited. - Liver disease: use cautiously and monitor hepatic function. - Asthma exacerbation: do not replace rescue inhalers during acute attacks. - Psychiatric effects: observe for mood changes or depressive symptoms. - Drug interactions: review all concomitant medications for potential effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Montelukast may interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma concentrations. - Phenobarbital: may reduce montelukast effectiveness. - Carbamazepine: may lower plasma levels of montelukast.

Moderate Interactions (Monitor Closely): - Fluconazole: may modestly raise montelukast levels. - Erythromycin: can increase systemic exposure. - Warfarin: monitor INR as montelukast may affect anticoagulation.